"It’s not yet clear how much the device will cost, Goodnow says, adding that the company is working now with insurers to negotiate cost. In general, he says, continuous glucose monitors in the United States tend to cost insurers about $10 a day. The cost to patients will depend on their own insurance plans, deductibles, and copays. It may be several more months before patients can obtain information about cost and insurance reimbursement, he says."

I cannot see where this is affordable in the areas where PharmaTech is marketing it's products.